Strategic B2B Sourcing for Hong Kong Ophthalmic Wholesalers & Private Clinics Sky High Medex is a specialized pharmaceutical exporter providing Combigan Eye Drops to licensed medical importers, private hospital networks, and ophthalmic specialists across Hong Kong. Manufactured by Allergan (an AbbVie company), Combigan is a premier fixed-dose combination therapy utilized for the professional management of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
B2B Order Details:
Minimum Order Quantity (MOQ): 50 Units (Strictly Wholesale).
Active Ingredients: Brimonidine Tartrate 0.2% and Timolol Maleate 0.5%.
Manufacturer: Allergan (AbbVie).
Therapeutic Class: Anti-Glaucoma Fixed-Dose Combination.
Format: Sterile Ophthalmic Solution.
The Sky High Medex Advantage for the Hong Kong Market:
Direct Export Economies: Optimize your procurement margins by sourcing directly from our Indian wholesale hub, offering significant cost efficiencies for high-volume ophthalmic requirements in the HK medical sector.
Allergan Global Standards: Benefit from the manufacturing excellence of a world leader in eye care, ensuring consistent potency, sterile integrity, and clinical reliability for specialized glaucoma management.
Verified Export Authority: We operate with a valid Import-Export Code (IEC) and GST registration, providing a 100% transparent and professional trade trail for Hong Kong-based professional entities.
Full Documentation Suite: Every shipment includes detailed commercial invoices and packing lists to support your internal compliance, auditing, and inventory management.
Logistics & Hong Kong Customs Support: While domestic import regulations and adherence to Department of Health (Drug Office) guidelines remain the responsibility of the importer, Sky High Medex ensures all Indian export formalities are handled with professional precision. We offer reliable air-freight shipping to Hong Kong International Airport (HKG), ensuring efficient transit for your bulk pharmaceutical orders.
Technical Insight & Clinical Applications: Combigan combines two effective agents to achieve superior IOP reduction compared to monotherapy. In the clinical context, it is recognized for:
Dual Mechanism of Action: Brimonidine (an alpha-2 adrenergic agonist) reduces aqueous humor production and increases uveoscleral outflow, while Timolol (a beta-blocker) primarily decreases aqueous humor secretion.
Improved Patient Adherence: The fixed-dose combination simplifies the treatment regimen, reducing the daily drop burden and improving long-term compliance for glaucoma patients.
Rapid & Sustained IOP Lowering: Clinical studies demonstrate a significant reduction in intraocular pressure, which is vital for preventing progressive optic nerve damage.
Sterile Formulation: Designed for long-term stability and consistent delivery via a specialized dropper system for safe topical application.
👉
📦 Request a Wholesale Quote for Hong Kong Contact our dedicated export desk for current batch availability and tiered bulk pricing.
WhatsApp: +91 9270847472
Email: skyhighmedex@gmail.com
Location: Nagpur Export Hub / International Service Desk
